289 related articles for article (PubMed ID: 31654704)
1. Selective inhibition of mTORC1/2 or PI3K/mTORC1/2 signaling does not prevent or modify epilepsy in the intrahippocampal kainate mouse model.
Gericke B; Brandt C; Theilmann W; Welzel L; Schidlitzki A; Twele F; Kaczmarek E; Anjum M; Hillmann P; Löscher W
Neuropharmacology; 2020 Jan; 162():107817. PubMed ID: 31654704
[TBL] [Abstract][Full Text] [Related]
2. The novel, catalytic mTORC1/2 inhibitor PQR620 and the PI3K/mTORC1/2 inhibitor PQR530 effectively cross the blood-brain barrier and increase seizure threshold in a mouse model of chronic epilepsy.
Brandt C; Hillmann P; Noack A; Römermann K; Öhler LA; Rageot D; Beaufils F; Melone A; Sele AM; Wymann MP; Fabbro D; Löscher W
Neuropharmacology; 2018 Sep; 140():107-120. PubMed ID: 30081001
[TBL] [Abstract][Full Text] [Related]
3. Brain-penetrant PQR620 mTOR and PQR530 PI3K/mTOR inhibitor reduce huntingtin levels in cell models of HD.
Singer E; Walter C; Fabbro D; Rageot D; Beaufils F; Wymann MP; Rischert N; Riess O; Hillmann P; Nguyen HP
Neuropharmacology; 2020 Jan; 162():107812. PubMed ID: 31622602
[TBL] [Abstract][Full Text] [Related]
4. Novel brain permeant mTORC1/2 inhibitors are as efficacious as rapamycin or everolimus in mouse models of acquired partial epilepsy and tuberous sclerosis complex.
Theilmann W; Gericke B; Schidlitzki A; Muneeb Anjum SM; Borsdorf S; Harries T; Roberds SL; Aguiar DJ; Brunner D; Leiser SC; Song D; Fabbro D; Hillmann P; Wymann MP; Löscher W
Neuropharmacology; 2020 Dec; 180():108297. PubMed ID: 32890589
[TBL] [Abstract][Full Text] [Related]
5. Discovery and Preclinical Characterization of 5-[4,6-Bis({3-oxa-8-azabicyclo[3.2.1]octan-8-yl})-1,3,5-triazin-2-yl]-4-(difluoromethyl)pyridin-2-amine (PQR620), a Highly Potent and Selective mTORC1/2 Inhibitor for Cancer and Neurological Disorders.
Rageot D; Bohnacker T; Melone A; Langlois JB; Borsari C; Hillmann P; Sele AM; Beaufils F; Zvelebil M; Hebeisen P; Löscher W; Burke J; Fabbro D; Wymann MP
J Med Chem; 2018 Nov; 61(22):10084-10105. PubMed ID: 30359003
[TBL] [Abstract][Full Text] [Related]
6. Various modifications of the intrahippocampal kainate model of mesial temporal lobe epilepsy in rats fail to resolve the marked rat-to-mouse differences in type and frequency of spontaneous seizures in this model.
Klee R; Brandt C; Töllner K; Löscher W
Epilepsy Behav; 2017 Mar; 68():129-140. PubMed ID: 28167446
[TBL] [Abstract][Full Text] [Related]
7. The mammalian target of rapamycin signaling pathway mediates epileptogenesis in a model of temporal lobe epilepsy.
Zeng LH; Rensing NR; Wong M
J Neurosci; 2009 May; 29(21):6964-72. PubMed ID: 19474323
[TBL] [Abstract][Full Text] [Related]
8. Significant effects of sex, strain, and anesthesia in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
Twele F; Töllner K; Brandt C; Löscher W
Epilepsy Behav; 2016 Feb; 55():47-56. PubMed ID: 26736063
[TBL] [Abstract][Full Text] [Related]
9. Canonical Wnt activator Chir99021 prevents epileptogenesis in the intrahippocampal kainate mouse model of temporal lobe epilepsy.
Mardones MD; Rostam KD; Nickerson MC; Gupta K
Exp Neurol; 2024 Jun; 376():114767. PubMed ID: 38522659
[TBL] [Abstract][Full Text] [Related]
10. Behavioral alterations in a mouse model of temporal lobe epilepsy induced by intrahippocampal injection of kainate.
Gröticke I; Hoffmann K; Löscher W
Exp Neurol; 2008 Sep; 213(1):71-83. PubMed ID: 18585709
[TBL] [Abstract][Full Text] [Related]
11. Targeting the Mouse Ventral Hippocampus in the Intrahippocampal Kainic Acid Model of Temporal Lobe Epilepsy.
Zeidler Z; Brandt-Fontaine M; Leintz C; Krook-Magnuson C; Netoff T; Krook-Magnuson E
eNeuro; 2018; 5(4):. PubMed ID: 30131968
[TBL] [Abstract][Full Text] [Related]
12. Recurrent seizures and hippocampal sclerosis following intrahippocampal kainate injection in adult mice: electroencephalography, histopathology and synaptic reorganization similar to mesial temporal lobe epilepsy.
Bouilleret V; Ridoux V; Depaulis A; Marescaux C; Nehlig A; Le Gal La Salle G
Neuroscience; 1999 Mar; 89(3):717-29. PubMed ID: 10199607
[TBL] [Abstract][Full Text] [Related]
13. The intrahippocampal kainate model of temporal lobe epilepsy revisited: epileptogenesis, behavioral and cognitive alterations, pharmacological response, and hippoccampal damage in epileptic rats.
Rattka M; Brandt C; Löscher W
Epilepsy Res; 2013 Feb; 103(2-3):135-52. PubMed ID: 23196211
[TBL] [Abstract][Full Text] [Related]
14. A guinea pig model of mesial temporal lobe epilepsy following nonconvulsive status epilepticus induced by unilateral intrahippocampal injection of kainic acid.
Carriero G; Arcieri S; Cattalini A; Corsi L; Gnatkovsky V; de Curtis M
Epilepsia; 2012 Nov; 53(11):1917-27. PubMed ID: 22998690
[TBL] [Abstract][Full Text] [Related]
15. A face-to-face comparison of the intra-amygdala and intrahippocampal kainate mouse models of mesial temporal lobe epilepsy and their utility for testing novel therapies.
Welzel L; Schidlitzki A; Twele F; Anjum M; Löscher W
Epilepsia; 2020 Jan; 61(1):157-170. PubMed ID: 31828786
[TBL] [Abstract][Full Text] [Related]
16. Agomelatine protects against neuronal damage without preventing epileptogenesis in the kainate model of temporal lobe epilepsy.
Tchekalarova J; Atanasova D; Nenchovska Z; Atanasova M; Kortenska L; Gesheva R; Lazarov N
Neurobiol Dis; 2017 Aug; 104():1-14. PubMed ID: 28438504
[TBL] [Abstract][Full Text] [Related]
17. Naringin attenuates granule cell dispersion in the dentate gyrus in a mouse model of temporal lobe epilepsy.
Jang H; Jeong KH; Kim SR
Epilepsy Res; 2016 Jul; 123():6-10. PubMed ID: 27040812
[TBL] [Abstract][Full Text] [Related]
18. The AMPA receptor antagonist NBQX exerts anti-seizure but not antiepileptogenic effects in the intrahippocampal kainate mouse model of mesial temporal lobe epilepsy.
Twele F; Bankstahl M; Klein S; Römermann K; Löscher W
Neuropharmacology; 2015 Aug; 95():234-42. PubMed ID: 25839899
[TBL] [Abstract][Full Text] [Related]
19. Repeated low-dose kainate administration in C57BL/6J mice produces temporal lobe epilepsy pathology but infrequent spontaneous seizures.
Umpierre AD; Bennett IV; Nebeker LD; Newell TG; Tian BB; Thomson KE; White HS; White JA; Wilcox KS
Exp Neurol; 2016 May; 279():116-126. PubMed ID: 26896834
[TBL] [Abstract][Full Text] [Related]
20. Naringenin ameliorates kainic acid-induced morphological alterations in the dentate gyrus in a mouse model of temporal lobe epilepsy.
Park J; Jeong KH; Shin WH; Bae YS; Jung UJ; Kim SR
Neuroreport; 2016 Oct; 27(15):1182-9. PubMed ID: 27584687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
